RLYB insider transaction filings
Rallybio Corp — 38 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-18. Screen RLYB transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Boudreau Helen M — Director | 1 | — | — | 2 |
| Chung Wendy — Director | 1 | — | — | 2 |
Recent Form 4 filings — Rallybio Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Chung Wendy — Director | Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0 | EDGAR |
| 2026-07-10 | 4 | Boudreau Helen M — Director | Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | ADAR1 Capital Management, LLC — 10% owner Schneeberger Daniel — 10% owner | Purchase (P): 6,009 @ $13.98 · Purchase (P): 10,000 @ $13.98 · Purchase (P): 200 @ $13.80 | EDGAR |
| 2026-05-15 | 4 | ADAR1 Capital Management, LLC — 10% owner Schneeberger Daniel — 10% owner | Purchase (P): 4,081 @ $13.80 · Purchase (P): 75,178 @ $14 · Purchase (P): 100 @ $13.80 · Purchase (P): 200 @ $13.95 | EDGAR |
| 2026-05-13 | 4 | ADAR1 Capital Management, LLC — 10% owner Schneeberger Daniel — 10% owner | Purchase (P): 5,100 @ $14.00 · Purchase (P): 25,000 @ $14 · Purchase (P): 19,900 @ $14 · Purchase (P): 800 @ $13.83 | EDGAR |
| 2026-05-06 | 4 | ADAR1 Capital Management, LLC — 10% owner Schneeberger Daniel — 10% owner | Purchase (P): 3,900 @ $13.90 · Purchase (P): 116,904 @ $13.97 · Purchase (P): 35,101 @ $14.00 | EDGAR |
| 2026-02-23 | 4 | Lieber Jonathan I — Chief Financial Officer | Grant/award (A): 2,500 @ $0 · Sale (S): 789 @ $5.06 | EDGAR |
| 2026-02-20 | 4 | MACKAY MARTIN — Director | Grant/award (A): 18,055 (derivative) @ $3.60 | EDGAR |
| 2026-02-20 | 4 | HUNT RONALD — Director | Grant/award (A): 14,305 (derivative) @ $3.60 | EDGAR |
| 2025-05-15 | 4 | Chung Wendy — Director | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Liu Hui — Director | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Soteropoulos Paula — Director | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Boudreau Helen M — Director | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Nash Christine A — Director | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Hopfner Robert Lorne — Director | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | MACKAY MARTIN — Director | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | HUNT RONALD — Director | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Ryder Steven — Chief Medical Officer | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Lieber Jonathan I — Chief Financial Officer | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Uden Stephen — Chief Executive Officer, Director | Grant/award (A): 453,700 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Liu Hui — Director | Grant/award (A): 67,857 (derivative) @ $0.70 | EDGAR |
| 2025-01-06 | 4 | Hopfner Robert Lorne — Director | Grant/award (A): 73,571 (derivative) @ $0.70 | EDGAR |
| 2025-01-06 | 4 | MACKAY MARTIN — Director | Grant/award (A): 92,857 (derivative) @ $0.70 | EDGAR |
| 2025-01-06 | 4 | HUNT RONALD — Director | Grant/award (A): 73,571 (derivative) @ $0.70 | EDGAR |
| 2024-05-17 | 4 | Liu Hui — Director | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Chung Wendy — Director | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Soteropoulos Paula — Director | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | PARMAR KUSH — Director | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Boudreau Helen M — Director | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Nash Christine A — Director | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Hopfner Robert Lorne — Director | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | HUNT RONALD — Director | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Ryder Steven — Chief Medical Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | MACKAY MARTIN — Executive Chairman, Director | Grant/award (A): 216,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Lieber Jonathan I — Chief Financial Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Uden Stephen — Chief Executive Officer, Director | Grant/award (A): 216,000 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | PARMAR KUSH — Director | Grant/award (A): 27,118 (derivative) @ $1.77 | EDGAR |
| 2024-01-04 | 4 | HUNT RONALD — Director | Grant/award (A): 29,096 (derivative) @ $1.77 | EDGAR |
Recent 8-K events — Rallybio Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-29 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-29 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RLYB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →